Trial intelligence / Profile preview

17-alpha-hydroxyprogesterone caproate versus vaginal progesterone for prevention of preterm birth in women with short cervix

IRCT2012082610664N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Preterm labor (PTL) comparing 17-alpha-hydroxyprogesterone caproate intramuscular with Vaginal progesterone suppository (2 arms). Started Nov 2012; status: completed.

02

Drugs

hydroxyprogesterone caproateprogesterone
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on IRCT2012082610664N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012082610664N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call